erythromycin has been researched along with ergotamine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
| Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Delaforge, M; Sartori, E | 1 |
| Bouzek, J; Jelínek, P; Kresnicka, J; Petr, P; Vambera, M | 1 |
| Francis, H; Tyndall, A; Webb, J | 1 |
| Collet, AM; Eissinger, F; Laselve, L; Moncharmont, D; Pinot, JJ; San Marco, JL | 1 |
| De Léan, J; Douville, Y; Ghali, R; Labbé, R; Noël, HP | 1 |
| Ashoush, R; Farah, E; Ghayad, E; Jebara, V; Karam, B | 1 |
| Bird, PA; Sturgess, AD | 1 |
14 other study(ies) available for erythromycin and ergotamine
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Specific drug binding to rat liver cytochrome P-450 isozymes induced by pregnenolone-16 alpha-carbonitrile and macrolide antibiotics. Implications for drug interactions.
Topics: Animals; Anti-Bacterial Agents; Cytochrome P-450 Enzyme System; Enzyme Induction; Ergotamine; Ergotamines; Erythromycin; Ethinyl Estradiol; Ethylmorphine; Ferricyanides; Isoenzymes; Male; Microsomes, Liver; Norethindrone; Prednisolone; Prednisone; Pregnenolone Carbonitrile; Rats; Rats, Inbred Strains; Spectrophotometry; Theophylline | 1990 |
[Acute ischemia of the extremities in the puerperal period].
Topics: Acute Disease; Adult; Drug Interactions; Ergotamine; Ergotism; Erythromycin; Extremities; Female; Humans; Ischemia; Pregnancy; Puerperal Disorders | 1990 |
Severe vascular spasm due to erythromycin-ergotamine interaction.
Topics: Acne Vulgaris; Adult; Drug Synergism; Ergotamine; Ergotamines; Erythromycin; Female; Humans; Intermittent Claudication; Ischemia; Kidney; Leg; Migraine Disorders | 1984 |
[Iatrogenic ergotism. Responsibility of an ergotamine tartrate-erythromycine propionate association (author's transl)].
Topics: Adult; Drug Therapy, Combination; Ergotamine; Ergotamines; Ergotism; Erythromycin; Humans; Ischemia; Leg; Liver Cirrhosis; Male | 1982 |
Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy.
Topics: Adult; Angiography; Drug Interactions; Ergotamine; Erythromycin; Female; Humans; Ischemia; Leg; Neural Conduction; Peripheral Nervous System Diseases | 1993 |
Ergotism precipitated by erythromycin: a rare case of vasospasm.
Topics: Abscess; Adult; Anti-Bacterial Agents; Caffeine; Drug Combinations; Ergotamine; Ergotism; Erythromycin; Humans; Ischemia; Male; Migraine Disorders | 2000 |
Clinical ergotism with severe bilateral upper limb ischaemia precipitated by an erythromycin--ergotamine drug interaction.
Topics: Anti-Bacterial Agents; Drug Synergism; Ergotamine; Ergotism; Erythromycin; Hand; Humans; Ischemia; Male; Middle Aged; Migraine Disorders; Respiratory Tract Infections | 2000 |